Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

420 with CNW — Marijuana Events Could Revive Atlantic City’s Glory

For decades, Atlantic City was a popular tourist destination for folks of all ages looking to enjoy the city’s diverse set of entertainment spots. Starting out as a resort town more than one hundred years ago, Atlantic City saw its fortunes change when Resorts International opened its casino doors in 1978.

The city peaked in 2006 with a revenue of some $5.2 billion behind Las Vegas’ revenue of $10.6 billion. However, Atlantic City’s fortunes have been on a decline ever since. The Taj Mahal Casino, owned by former president Donald Trump, shut its doors in 2016, and the Revel Casino Hotel was sold in 2018.

Now that dozens of states have legalized cannabis, Atlantic City may be able to regain some of its former glory by taking advantage of the tremendous demand for cannabis. Marijuana has proven to be an extremely lucrative product, generating billions of dollars in taxes and providing hundreds of thousands of employment opportunities.

For starters, dispensaries in New Jersey had sold $24 million worth of recreational cannabis just one month after legal adult-use cannabis sales launched, representing the industry’s immense potential.

A recent Skift Meetings report found that cannabis has the potential to alleviate the city’s financial woes and help its economy recover. Since Atlantic City has more than 15,000 hotel rooms, it is a perfect place to hold large cannabis conventions. Cannabis trade shows such as CHAMPS trade shows or MJBizCon can bring in tens of thousands of tourists and generate significant revenue for the city.

Speaking at the Skift Meetings, Bridge Strategic Communications president Stu Zakim said that the city could be a wildly successful destination for cannabis conventions that require large facilities. Larry Seige, president and CEO of AC, was in agreement, stating that cannabis legalization laws have opened up a new market for meetings and conventions in the city that will have a significant economic impact.

According to the 3rd annual New Jersey Cannabis Convention (NECANN), which will be held at the Atlantic City Convention Center from Sept. 9–10, 2022, Atlantic City’s cannabis market is huge, untapped and brimming with potential. The state of New Jersey legalized recreational cannabis in February, and the industry, which is already generating millions of dollars in sales, has significant potential for growth.

Projections from MJBizdaily show that New Jersey’s recreational cannabis market is projected to achieve a valuation of $2 billion in 2026 from $625 to $775 million in 2021.

These high sales figures show just how huge the potential market for cannabis products from companies such as American Cannabis Partners can be once there are reforms at the federal level and prohibition is ended.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) GrowPods Strengthen Company’s Position in Growing Multibillion-Dollar Market

The global indoor farming market projected to grow from $26.5 billion in 2021 to $62 billion by 2030
Report indicates that United States holds major share in terms of revenue in North America indoor farming market
Grow Pods offered through ACTX provide a controlled environment, ability to grow year-round

The newest projections for the global indoor farming sector are in, and the numbers bode well for Advanced Container Technologies (OTC: ACTX). ACTX is the exclusive U.S. distributor of Grow Pods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long.

“The study undertaken by Astute Analytica foresees a tremendous growth in revenue of the market for the global indoor farming market from US$26.5 billion in 2021 to US$62 billion by 2030,” a recent PR Newswire report states (https://cnw.fm/sIUv2). “The market is anticipated to grow at a CAGR of 10.1% during the forecast period 2022–2030.

The article notes that indoor vertical farming is defined as the practice of growing produce stacked one above another in a closed, controlled environment. “Growing crops on vertically mounted shelves significantly reduces the amount of land space needed to grow plants compared to traditional farming methods,” the article observes.

“Vertical farms are unique in the sense that some setups do not require soil for plants to grow,” the article continues. “Most are either hydroponic, where vegetables are grown in a nutrient-dense bowl of water, or aeroponic, where the plant roots are systematically sprayed with water and nutrients. Moreover, vertical farms use smart sensors to monitor technical variables including temperature, carbon dioxide, oxygen, lighting, humidity, nutrient concentration, pH, pest control, irrigation and harvesting.”

The Astute Analytica report showed that the United States holds the major share in terms of revenue in the North America indoor farming market, with projections to grow with the highest CAGR during the forecast period. “Moreover, developed countries such as U.S. and Canada are the rapid and early adopters of indoor farming technologies,” the article said. “Furthermore, based on the growing system, the hydroponics segment holds the highest share in the North America indoor farming market in 2021 as it reduces the amount of space and water required for cultivation.”

Offering the ability to grow high-quality crops anywhere, the Grow Pods offered through Advanced Container Technologies provide a controlled environment and the ability to grow year-round. The micro-farms also enable cultivation in a smaller footprint using less resources — huge advantages in a world where environmental and sustainability concerns are top priorities for consumers.

In November 2020, ACTX announced that it had entered into an agreement with Grow Pods manufacturer GP Solutions for the exclusive right to market, sell and distribute GP products in the United States and its territories (https://cnw.fm/MZKeB). At the time of the agreement, GP Solutions president George Natzic stated that “we are very enthusiastic about this agreement and look forward to letting the experts at ACT handle sales and marketing while we focus on manufacturing new products, and expanding into new industries and territories.”

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Reach of its Drug Delivery Technology Through Newly Inked Agreements with Beverage Developer BevNology

Drug delivery technology innovator Lexaria Bioscience has developed a patented technology showing superiority in animal and human testing as a means of improving existing drug brands’ performance and establishing new solutions for unmet medical needs
The company recently announced agreements with beverage developer BevNology to expand production capabilities for Lexaria’s own growing list of B2B clientele and empowering BevNology to offer DehydraTECH products with active ingredients derived from hemp including CBD under BevNology and partnered brands
The technology is called DehydraTECH — improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery
Lexaria also recently announced an agreement with Ireland’s Anodgen Bioceuticals that allows Anodgen to manufacture and distribute DehydraTECH processed cannabinoid API powders within Europe including the UK, Australia and New Zealand

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has built the reputation of its patented DehydraTECH drug delivery technology through a growing data set of potential medicinal applications and through an expanding list of licensing agreements with third-party companies interested in its potential for cannabidiol (“CBD”)-based products.

Lexaria’s patented DehydraTECH technology transforms a wide variety of orally and topically administered products into enhanced solutions that make the APIs more rapidly available and effective at lower doses while adding zero chemical byproducts.

Among the licensing partnerships announced by the company are recent agreements with beverage developer BevNology and Ireland API manufacturer and distributor Anodgen Bioceuticals.

The BevNology collaboration was announced June 21 and not only includes a commercial license agreement for products with active ingredients derived from hemp under BevNology’s brand, but also a manufacturing operating agreement utilizing BevNology’s new, custom-built state-of-the-art processing facility outside Atlanta.

“These agreements build on a long standing and very successful product development consulting relationship between Lexaria and the expert scientists and personnel at BevNology,” Lexaria CEO Chris Bunka stated in announcing the BevNology development (https://cnw.fm/6it3Q). “BevNology’s formulation and production capabilities are class leading and we are confident that our new relationship with our trusted partner will propel new and exciting growth opportunities for both companies.”

The manufacturing agreement will help Lexaria broaden its production capabilities for its own growing list of B2B clientele interested in purchasing DehydraTECH-powered active ingredients for consumer packaged-goods brands. Lexaria has already installed all required commercial DehydraTECH manufacturing equipment at the facility.

The licensing agreement addresses powdered DehydraTECH formulations and liquid formulations that tend toward BevNology’s particular expertise. Both elements of the agreement are non-exclusive, except that the liquid formulations have limited exclusivity in the United States and complete exclusion in Japan, the Republic of Korea, and the People’s Republic of China.

The Anodgen licensing agreement was announced earlier in the month and includes a five-year non-exclusive DehydraTECH license for powdered CBD-based products in Europe including the United Kingdom, Australia, and New Zealand.

Under the license, Anodgen can use DehydraTECH not only for making and selling medical application CBD products but also pharmaceutical applications for psychoactive cannabinoids (https://cnw.fm/JjYBn). Anodgen is building a new facility in Ireland and expects to be fully operational later this year, creating the potential for long-term use of DehydraTECH for the pharmaceutical market.

Independent third-party testing has evidenced DehydraTECH’s ability to enhance the performance of a variety of pharmaceutical and wellness industry products and has led to a pre-Investigational New Drug (“IND”) meeting with the U.S. Food and Drug Administration (“FDA”) to file DehydraTECH-CBD as a prospective registered treatment for hypertension this year (https://cnw.fm/M6RAk).

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — NIDA Seeks Help in Creating Nationwide Registry of Medical Cannabis Use

By the end of last year, more than 30 states had launched some kind of medical cannabis market. But with each state independently passing its own policies, this has led to a patchwork of different medical cannabis legislation across the country. Last week, a top federal agency revealed that it plans on creating a countrywide medical cannabis registry that would allow it to study how patients use medical marijuana.

The National Institute on Drug Abuse (NIDA) has pledged to provide funding worth $1.5 million to researchers to help them develop a nationwide medical cannabis registry capable of tracking how medical cannabis patients in all legal states obtain and use medical cannabis as well as their medical outcomes. As NIDA stated in its request for applications (RFA), three-quarters of the states in the country have legalized medical cannabis, although each state has varying conditions regarding qualifying medical conditions and the types of medical marijuana products patients are allowed to use.

This patchwork landscape makes it extremely difficult for the agency to analyze medical cannabis use and how it is impacting the public. The information that is available is not standardized and cannot be used to understand the broader health outcomes associated with medical cannabis use, the agency explained.

NIDA also noted that there is little standardized information regarding the medical marijuana products being used because of lax laws surrounding labeling. As such, the agency will need to collect all the relevant information on medical cannabis products.

This registry will allow NIDA to study how different medical cannabis products affect patients and obtain a clearer idea of potential risks and benefits. According to the agency’s request for applications, the objective of this new information-gathering process is to find out which medical marijuana products are being used, the reasons why they are being used and the outcomes of use.

The agency is looking for a wide dataset from the medical cannabis industry that includes cannabis strains, cannabis forms, delivery methods, most prevalent cannabinoids, medical marijuana card status and the symptoms being addressed by medical cannabis treatment. NIDA is also interested in information pertaining to changes in other pharmaceutical and illicit drug use after the onset of medical marijuana treatment, as well as interactions between cannabis and other drugs.

Researchers who would like to take part in creating the registry and keeping it up to date can begin submitting applications on Oct. 15, 2022. They will be allowed to send in their applications for NIDA funding until Nov. 16, 2022.

These moves by federal agencies such as NIDA offer a ray of hope that real reforms may not be far off and industry actors, such as Flora Growth Corp. (NASDAQ: FLGC), may finally have a framework within which to operate nationally.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Colorado Study Finds Teen Cannabis Use Reduced Massively in 2021

A recent study of Colorado’s marijuana industry has revealed a fact that has been consistent in other states with legal cannabis markets: teen cannabis use is on the decline. Prohibitionists across the country had argued that legalizing adult-use cannabis would make the controversial drug more accessible and lead to increased drug use by the youth.

However, several studies have found that legalization has actually had the opposite effect, limiting youth access and reducing the number of young teens who consume cannabis. According to the recent Colorado study, 2021 saw an especially “dramatic” drop in cannabis use by teens. Dubbed the Healthy Kids Colorado Survey, the biennial state poll was carried out by the Colorado Department of Public Health and Environment (CDPHE).

The agency found that young teens were 35% less likely to consume cannabis in 2021 compared to previous years. This is reflective of several prior studies that have contradicted prohibitionists’ claims that legalizing cannabis would have an adverse effect on the country’s youth. However, we should note that the coronavirus pandemic may have played a part in reducing youth cannabis use by keeping potential users in socially isolated conditions.

Either way, it is clear that cannabis reform policies have made it at least a little harder for students to access cannabis. According to the CDPHE’s new study, slightly more than 13% of the surveyed teens said they had consumed cannabis within the past 30 days compared to 20% back in 2013 when the agency first launched the Healthy Kids Colorado Survey.

NORML deputy director Paul Armentano says the Colorado study is consistent with the growing body of literature showing that it is entirely possible to launch a controlled recreational cannabis market for adults aged 21 and older while limiting access to underage individuals.

The 2021 study also revealed that more othan 40% of students found it easy to access cannabis when they were so inclined compared to almost 55% in 2013, a year before the state legalized cannabis and launched a controlled market. Furthermore, more than 60% of the respondents associated cannabis use with “moderate or great risk of harm,” compared to 54% in 2013.

This signifies a shift in how teens see cannabis and its perceived risks and benefits. Prohibitionists had feared that legalizing cannabis would cause youngsters to view it as completely safe, but the study shows youth aren’t looking at cannabis use through rose-tinted glasses.

Senator John Hickenlooper, formerly the governor of Colorado, was not a fan of legalization because he believed that it would encourage drug abuse among the state’s youth. More than a decade later, however, he acknowledges that his fears were unfounded and cannabis youth use is actually declining. He also praises the state’s cannabis industry, stating that legislators “created a good framework” that has been copied by several other states.

The findings of this Colorado study provide further proof that it wasn’t a mistake to open legal marijuana markets in which entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS) can operate.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Prime Harvest Inc.’s Jaxx Carving out Top Spot in Cannabis World

Prime Harvest’s Jaxx Cannabis is poised in the cannabis world with its outstanding, renowned customer service and quality products. “The flagship brand in a portfolio of superior offerings from Prime Harvest, Jaxx features an expertly curated selection of premium products from some of the most respected brands in the thriving California market. Jaxx products are carefully selected to combine value and quality to create an experience focused and centered on consumers… Visitors to both brick-and-mortar and online stores can choose from an array of categories, including flower, pre-rolls, vaporizers, concentrated, edibles, tinctures, and topicals. Jaxx enthusiasts can even order from a complete line of accessories, including everything from bowls and spoons to entire starter kits, as well as Jaxx swag, including t-shirts, hats and consumption accessories. Committed to empowering and changing lives, Jaxx excels at helping consumers find the right products for their unique lifestyles,” a recent article reads. “Jaxx places customers at the front and center… From the moment a potential customer steps inside the Jaxx world to the moment a consumer starts enjoying the cannabis experience they were looking for, Jaxx offers unparalleled support, assistance and service every step of the way.”

To view the full article, visit https://cnw.fm/AWad2

About Prime Harvest Inc.

Prime Harvest is a technology-focused full-service cannabis corporation. The company is horizontally diversified across various segments of the cannabis value chain, including licensing acquisition and compliance management, and state-wide direct-to-consumer operations. Based in the innovation hotspot of San Diego, California, Prime Harvest is expanding its footprint throughout the Golden State by executing a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology. Prime Harvest’s flagship retail brand, Jaxx Cannabis, upholds exceptional standards of quality and services and provides a rewarding experience for customers in San Diego and the surrounding Southern California communities. Trust and credibility are at the heart of everything that the team at Prime Harvest stands for. The Prime Harvest team is composed of true experts in their respective fields, carefully assembled with the aim of building a world-class organization that can drive the cannabis industry and movement forward. For more information about the company, visit www.PrimeHarvestInc.com.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest are available in the company’s newsroom at https://cnw.fm/PRIME

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Flora Growth Corp. (NASDAQ: FLGC) Authorizes the Repurchase of up to $5 Million Shares

Flora Growth Corp. announced that the Company Board has authorized the repurchase of up to $5 million of its outstanding common shares
Luis Merchan, Flora’s Chairman and CEO, said that Flora is executing its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses
At the closing of 2021, the company announced a 2022 revenue guidance projection of $35-45 million

Flora Growth (NASDAQ: FLGC) is a global leader in the cultivation, marketing, and distribution of premium-quality cannabis products and brands at below-market prices. Flora Growth recently announced that the company’s Board of Directors (the “Board”) has authorized the repurchase of up to $5 million of its outstanding common shares subject to market conditions and the company’s liquidity warrant (https://cnw.fm/9m47y).

Luis Merchan, Flora’s Chairman and CEO, stated that the potential to repurchase their shares at these levels represents a compelling opportunity to deploy available cash to drive shareholder value. The company’s board believes that the decline in the market price of shares is due to the generally weak financial market and cannabis sector. It is also attributed to the recent selling of several millions of shares by certain shareholders who acquired such shares at a very low-cost basis, prior the company’s had its IPO, and who had previously been subject to a one-year lockup period which expired in mid-May.

Repurchases may be made from time to time through open market purchases, and, in no event shall the company repurchase more than five percent of the total number of issued and outstanding shares as of the repurchase date.

Flora’s 249-acre cultivation facility Cosechemos, based in Colombia, is the core of the company’s business model. The ideal location, resources, and climatic conditions at the Cosechemos farm, enable Flora’s low production cost which is approximately $0.06/gram, compared to production costs that can be as high as $1/gram or more in parts of North America (https://cnw.fm/gptGk).

On Feb 22, 2022, Columbia’s President Duque approved a previously announced legislation expanding on Resolution 811. The new Resolution 227 allows the industrial use of cannabis in sectors such as food, beverages and textile. This new regulation will further pave way for increased revenues for the company (https://cnw.fm/WfqLT). Recently, Flora also solidified its foothold in the U.S., by acquiring the luxury cannabis consumer brand Vessel Brand Inc.

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Sugarmade Inc. (SGMD) Announces First Transaction Under Cannabis Global Inc. Contract

SGMD will produce an estimated 25,000 pounds of Fresh Frozen cannabis, which Cannabis Global will use in its product lines
The market for Fresh Frozen cannabis is “snowballing,” says Cannabis Global CEO
With the rapid Fresh Frozen harvesting process, airtight storage and near cryogenic storage temperatures, almost all of the natural cannabis plant essence is preserved

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is seeing the fruit of its labors, so to speak. The company recently announced the first transaction under its previously announced contract with Cannabis Global (OTC: CBGL). The transaction calls for Sugarmade to produce an estimated 25,000 pounds of Fresh Frozen cannabis, which Cannabis Global will use in its product lines and will distribute to the California marketplace (https://cnw.fm/srEmn).

Sugarmade and Cannabis Global have signed a prebooked, fixed-price contract in the amount of $700,000; that payment includes cash payments from Cannabis Global to Sugarmade of $300,000 and notes for the balance of $400,000. Planting of the cultivators began in mid-May and will continue into early June.

“The market for Fresh Frozen cannabis is snowballing,” said Cannabis Global CEO Arman Tabatabaei. “Thus we believe it is the place to be for the 2022 cultivation season. We plan to process a large portion of the 25,000 pounds of ultra-premium cannabis at our Lynwood, California, laboratory, creating premium solventless extracts for sale into the market and for use in our own manufactured products, thus creating vertical integration to reduce our costs of goods sold.

“We also plan to store a significant portion of the biomass in the Los Angeles area to create an active wholesale market to the many new solventless extractors in the area via our wholly owned distribution company, Northern Lights Distribution,” Tabatabaei continued. “We have integrated this cultivation effort into our strategic plan for 2022 and 2023b as an important component to further boost our already fast-growing revenue base.”

Fresh Frozen cannabis is flash frozen immediately after harvest instead of undergoing the traditional treatment of drying and curing. A growing number of cannabis consumers are choosing this type of cannabis as they seek naturally produced cannabis products full of natural plant terpenes and flavors. As demand grows, the number of products available that contain Fresh Frozen cannabis is also growing.

“In many ways, the advent of Fresh Frozen-oriented cannabis cultivation has turned the cannabis cultivation model on its head,” a recent article observed. “Where cultivators traditionally harvested cannabis plants and then spent weeks or months drying, curing and processing plant materials, all the while battling heat, humidity, molds and other factors that could affect the product.

“Fresh Frozen-oriented cultivation allows growers to ditch the traditional model by cutting down the plants at the peak of freshness, stripping the large leaves, branches and stems and then bagging the remaining materials bound for storage in industrial freezers at temperatures well below -5 F,” the article continued. “With the rapid harvesting process, airtight storage and near cryogenic storage temperatures, almost all of the natural cannabis plant essence is preserved.”

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue and Lemon Glow.

For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Brazilian Superior Court Authorizes Home Cultivation of Marijuana for Medical Use

The wave of cannabis reform that began rocking the world when jurisdictions within the United States and countries such as Uruguay and Canada legalized marijuana in various forms has now arrived in Brazil. Earlier this week, a top Brazilian court gave a trio of patients authorization to grow their own cannabis at home for medical treatment. Although the country’s health ministry still hasn’t issued regulations for at-home cultivation of cannabis, this ruling may set a precedent that could be applied across the country.

A panel of five judges from the Brazil Superior Court of Justice all agreed that the medical marijuana patients in question should be allowed to grow marijuana at home and extract its oil to use as a pain medication. According to Judge Rogério Schietti, the government’s failure to issue scientific guidelines on the issue forced the panel’s hand. He called most of the arguments against cannabis reform “moralistic,” arguing that they tended to have a religious nature and were based on false truths and stigmas.

This sense of moralism has delayed the development of legislation to regulate at-home cultivation and clouded the minds of local judges. He emphasized that the country needed to end this prejudice against marijuana and take a scientific position on cannabis reform, not a religious one.

Judge Antonio Saldanha, another member of the panel, added that the government’s delay in issuing guidelines for at-home cultivation of medical cannabis was a conscious “backward step to obscurantism.” The country’s main health body, the Brazilian Agency Regulatory Agency (ANVISA), has denied requests to allow home cultivation on a number of occasions.

Two years ago, Daniel Law and the Cannigma reported that ANVISA had begun authorizing the import, manufacture and sale of cannabis-based medications as well as the commercialization of medical as well as recreational marijuana. However, this seems to go against Brazilian law, which only allows imported cannabis products for medical use.

By law, only three companies are authorized to grow, harvest and handle medical marijuana. These companies include the Cannabis and Health Association, the Brazilian Cannabis Support Association Esperança and the Support for Medical Cannabis Research and Patients.

Last year, the country’s far-right president, Jair Bolsonaro, declared that he did not support any efforts to authorize home cultivation of cannabis, even if it was for medical purposes. This is despite the fact that a prior survey from the International Drug Policy Consortium found that more than one-half (57%) of Brazilians were in favor of legalizing cannabis.

The authorization of cannabis home-grows for the patients who petitioned the court may open a deluge of interested parties that wish to leverage modern cannabis growing technologies and opportunities such as the grow pods sold by Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Top White House Drug Chief Says Feds are Reviewing Cannabis Policies

President Joe Biden based his campaign on renewable energy, infrastructure and cannabis decriminalization. Months after he assumed office, President Biden was working on a massive infrastructure bill that would invest hundreds of millions of dollars in the transition to cleaner energy sources. On the other hand, he hasn’t made any efforts to keep his cannabis campaign promises in the year and a half since he was inaugurated as the 46th president of the United States.

However, the word from a high-level White House official is that Biden’s administration is “monitoring” states with legal cannabis markets to help inform federal cannabis policy. The director of the Office of National Drug Control Policy (ONDCP) said in an interview with the Financial Times that the administration is currently learning from states that have already passed some kind of cannabis reform.

He stated that officials were looking into broad harm-reduction proposals, including supervised drug consumption sites for people suffering from addiction and even federal decriminalization. Gupta also said that Biden had made it clear that current marijuana policies were far from effective.

Gupta noted that this will be the first time America’s federal government is espousing harm-reduction policies rather than a prohibitionist approach. He emphasized that people shouldn’t be arrested or incarcerated for drug use, especially when people of color are several times more likely to be arrested and charged for drug use despite near-identical use rates with white people.

Even if the Biden administration doesn’t pass comprehensive cannabis reform, putting an end to drug-related arrests and incarcerations would basically amount to decriminalization from a policy perspective. Biden himself has stated that he does not support comprehensive reform or launching a recreational cannabis market at the federal level. Rather, he believes in passing medical marijuana legislation and letting individual states figure out how they want to regulate cannabis on their own.

One of the harm-reduction policies that are under review is the controversial safe consumption sites that would allow people who are currently addicted to illegal drugs to gain increased access to addiction treatment resources, hopefully reducing the number of overdose deaths.

Gupta says that the administration already has a proposal that would lift the ban on safe-consumption sites even though the efficiency of such centers is still in question. Officials from America’s first authorized harm reduction centers in New York City say the centers have been quite effective and are already saving lives.

As the federal administration warms up to the idea of legalizing or at least decriminalizing marijuana production, possession and consumption, the market served by licensed entities such as American Cannabis Partners is likely to explode nationwide.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.